{"id":314464,"date":"2025-12-13T20:32:14","date_gmt":"2025-12-13T20:32:14","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/314464\/"},"modified":"2025-12-13T20:32:14","modified_gmt":"2025-12-13T20:32:14","slug":"should-everybody-be-taking-ozempic","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/314464\/","title":{"rendered":"Should everybody be taking Ozempic?"},"content":{"rendered":"

Front Burner<\/a><\/p>\n

We examine the rise and risks of blockbuster drugs like Ozempic, after the WHO conditionally recommended GLP-1s for the long-term treatment of obesity.\n<\/p>\n

CBC News \u00b7 Posted: Dec 11, 2025 4:00 AM EST | Last Updated: December 11<\/p>\n

\"Text<\/p>\n

Listen to this article<\/p>\n

Estimated 1 minute<\/p>\n

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results.<\/p>\n

\"TwoOzempic boxes and injector. (Turgut Yeter\/CBC)LISTEN | FRONT BURNER:<\/p>\n

Front Burner25:34Should everybody be taking Ozempic?<\/p>\n

It’s estimated that as many as 10 per cent of adults in Canada use a GLP-1 type drug like Ozempic. The prescription medicine is used for type 2 diabetes management and increasingly prescribed off-label for weight loss. And this month, for the first time, the World Health Organization has conditionally recommended GLP-1 drugs for the long-term treatment of obesity.<\/p>\n

But while these drugs have been called a game-changing tool to manage a complex and stigmatized health condition, there\u2019s also a lot of questions about the potential negative impact.<\/p>\n

With Ozempic\u2019s patent set to expire soon in Canada, and more affordable generic options about to hit the market, a lot more people you know could end up on a weight-loss drug.<\/p>\n

Today we bring you the rise and risks of GLP-1s with help from Dylan Scott. He is a Senior Correspondent at Vox who covers health.<\/p>\n

For transcripts of Front Burner, please visit:\u00a0https:\/\/www.cbc.ca\/radio\/frontburner\/transcripts<\/a><\/p>\n

Subscribe to Front Burner on your favourite podcast app.<\/p>\n

Listen on Apple Podcasts<\/a><\/p>\n

Listen on Spotify<\/a><\/p>\n

Listen on YouTube<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"Front Burner We examine the rise and risks of blockbuster drugs like Ozempic, after the WHO conditionally recommended…\n","protected":false},"author":2,"featured_media":314465,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[102,6591,56,54,55],"class_list":{"0":"post-314464","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-uk","11":"tag-united-kingdom","12":"tag-unitedkingdom"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/314464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=314464"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/314464\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/314465"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=314464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=314464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=314464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}